They build our bodies and orchestrate the molecular processes in cells that keep them healthy. They also present a wealth of targets for new medications. From everyday pain relievers to sophisticated ...
In five years since AlphaFold's debut, it has transformed basic biochemical research. But its long-term effect on drug discovery remains unclear.
When John Jumper got the call earlier this month from the Royal Swedish Academy of Sciences that he was winning the Nobel Prize, he almost didn’t answer. The director of Google DeepMind, the tech ...
The AI tool AlphaFold has been improved so that it can now predict the shape of very large and complex protein structures. Researchers have also succeeded in integrating experimental data into the ...
Google Deepmind has unveiled the third major version of its “AlphaFold” artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the ...
Mapping proteins unlocks clues to preventing and treating illnesses. Here’s how DeepMind’s AlphaFold is accelerating this research exponentially. In 1997, while Demis Hassabis was a student at ...
Google DeepMind, Google LLC’s artificial intelligence research unit, today detailed a new version of its AlphaFold neural network for biologists. One of the factors that influence the behavior of a ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Google DeepMind and Isomorphic Labs today ...
Pharmaceutical researchers in the United Kingdom are using the artificial intelligence tool AlphaFold to develop new psychedelic drugs, according to research released last month. The research, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback